Your browser doesn't support javascript.
loading
Appropriate use of tocilizumab in COVID-19 infection.
Keske, Siran; Tekin, Süda; Sait, Bilgin; Irkören, Pelin; Kapmaz, Mahir; Çimen, Cansu; Ugur, Semra; Çelebi, Irfan; Bakir, Veli Oguzalp; Palaoglu, Erhan; Sentürk, Evren; Çaglayan, Benan; Çakar, Nahit; Tabak, Levent; Ergönül, Önder.
Afiliação
  • Keske S; American Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
  • Tekin S; Koç University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
  • Sait B; American Hospital, Department of Internal Medicine, Istanbul, Turkey.
  • Irkören P; Koç University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
  • Kapmaz M; Koç University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
  • Çimen C; American Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey.
  • Ugur S; Koç University, School of Medicine, Department Anesthesiology & Intensive Care Unit, Istanbul, Turkey.
  • Çelebi I; American Hospital, Department of Radiology and Beykent University School of Medicine, Turkey.
  • Bakir VO; Koç University, College of Engineering, Department of Industrial Engineering, Istanbul, Turkey.
  • Palaoglu E; American Hospital, Clinical Laboratory, Istanbul, Turkey.
  • Sentürk E; Koç University, School of Medicine, Department Anesthesiology & Intensive Care Unit, Istanbul, Turkey.
  • Çaglayan B; Koç University, School of Medicine, Department of Chest Diseases, Istanbul, Turkey.
  • Çakar N; Koç University, School of Medicine, Department Anesthesiology & Intensive Care Unit, Istanbul, Turkey.
  • Tabak L; Koç University, School of Medicine, Department of Chest Diseases, Istanbul, Turkey.
  • Ergönül Ö; Koç University, School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey. Electronic address: oergonul@ku.edu.tr.
Int J Infect Dis ; 99: 338-343, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32726724
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Oxigênio / Pneumonia Viral / Biomarcadores / Infecções por Coronavirus / Pandemias / Anticorpos Monoclonais Humanizados / Betacoronavirus Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Infect Dis Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Oxigênio / Pneumonia Viral / Biomarcadores / Infecções por Coronavirus / Pandemias / Anticorpos Monoclonais Humanizados / Betacoronavirus Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Infect Dis Ano de publicação: 2020 Tipo de documento: Article